Imagene

Immediate Oncology Intelligence

Health Tech & Life Sciences
Active
Series B Tel Aviv-Yafo, Israel Founded 2020
Last updated 2026-06-18
Total raised
$44.5M
Last: 2025-07
Stage
Series B
Founded
2020
Headcount
33
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Imagene was founded with a clear mission to leverage AI to profile, in real time, a broad range of biomarkers from biopsy images. By doing so, the company aims to overcome economical, logistical, and technological barriers to reach the full potential of precision medicine for all cancer patients. Imagene's technology classifies patterns that cannot be seen by the human eye, evolving genomics, proteomics, and spatial insights, resulting in a fast and accurate molecular profiling. The company's technology also enables better stratification of patients for clinical trials and the discovery of novel targets for new drugs.

Imagene collaborates with top-tier medical centers and pharmaceutical companies worldwide. It was selected for The Marker's Most Promising Start-Ups for 2022, and named Oncology Innovation of the Year by the BioTech Breakthrough Awards.

Through collaborations with top-tier medical centers and pharmaceutical companies, Imagene is working to revolutionize molecular screening for both clinical practice and research.

Funding history · 3 rounds · $44.5M total

Q&A

What is Imagene's primary mission?
Imagene's primary mission is to leverage AI to profile a broad range of biomarkers from biopsy images in real time, aiming to overcome barriers to precision medicine for cancer patients.
When was Imagene founded?
Imagene was founded in January 2020.
How many employees does Imagene have?
Imagene has 33 employees, falling within the 11-50 employee bucket.
What is Imagene's total funding to date?
Imagene has raised a total of $44,500,000 USD.
Which investors participated in Imagene's July 2025 funding round?
Imagene's July 2025 funding round included Larry Ellison and Aguras.
What is Imagene's current funding stage?
Imagene is currently in its Series B funding stage.
Where is Imagene's headquarters located?
Imagene's headquarters is located in Tel Aviv-Yafo, Israel.
What technologies does Imagene utilize?
Imagene utilizes Artificial Intelligence, Deep Learning, and Computer Vision technologies.
Who are the co-founders of Imagene?
The co-founders of Imagene are Dean Bitan (Co-founder & CEO), Shahar Porat (Co-founder & CTO), and Jonathan Zalach (Co-founder & Chief Data Scientist).

Team · 3

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗
Founder · Co-founder & Chief Data Scientist
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceDeep LearningComputer Vision
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatientsProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

biomarkersreal-timepharma-companiesdoctorsdeep-learningoncologycancerdigital-healthcarepatientshospitalspersonalizationhealthcare-providersartificial-intelligencehealthcarediagnosticsprecision-medicinecomputer-vision
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)